Onzetra Xsail sumatriptan nasal powder regulatory update

FDA approved an NDA from Otsuka’s Avanir Pharmaceuticals Inc. subsidiary for Onzetra Xsail sumatriptan nasal powder to treat acute migraine with or without aura in adults. Avanir plans to launch Onzetra Xsail “in the coming months.” ...